Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

BP guidance is not in real world

I foresee hospital referrals going through the roof for ambulatory blood pressure monitoring. Buying in expensive equipment is only realistic for big practices who have enough money in the pot to make a big initial outlay.

NICE predicts making such investments will cut down the drug budget and save money in the long run. Will practices have to use their own cash to buy in the equipment?

If so, will the money that has been saved on cutting down drug use go to the practices? I doubt it. Not much incentive, really. GPs will end up referring to secondary care, which will cause headaches for commissioning groups. NICE is not thinking about what will happen in the real world.

From Dr Julian Hall,
Halesowen, West Midlands

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say